Back to search

Article

Considerations on implementation of the newest treatment for symptomatic uterine fibroids: oral GnRH antagonists.

2023-02-23

Abstract excerpt

Novel Gonadotrophin Releasing Hormone (GnRH) antagonist treatments have recently been developed in combination with hormonal add-back therapy, as an oral treatment option for women suffering from uterine fibroids. Registration trials assessing the GnRH antagonist combination preparations with relugolix, elagolix, and linzagolix have assessed treatment efficacy for fibroid related heavy menstrual blood loss in comp...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
aab3b1fe-6c8a-5fc6-92e3-8ae2f5587d08
DOI
10.22541/au.167716085.54111521/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Considerations on implementation of the newest treatment for symptomatic uterine fibroids: oral GnRH antagonists.DOI 10.22541/au.167716085.54111521/v1
Select a neighboring publication to make it the new centre.